an experimental experience

8/7/23 at 1:56pm

Organization

Author

Phalguni Deswal

27 words

Comments

Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in the last quarter of 2023.

You are the first to view

http://www.pharmaceutical-technology.com/news/fda-approves-first-oral-treatment-postpartum-depression/

Create an account or login to join the discussion